| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.75M | 117.18M | 114.26M | 97.75M | 80.48M | 55.98M |
| Gross Profit | 26.99M | 28.62M | 29.03M | 18.96M | 15.89M | 11.92M |
| EBITDA | 887.00K | 555.00K | 2.37M | 7.77M | 4.71M | 7.49M |
| Net Income | -1.08M | -1.44M | 427.00K | 5.16M | 3.29M | 5.70M |
Balance Sheet | ||||||
| Total Assets | 29.68M | 37.88M | 34.36M | 32.85M | 25.35M | 23.31M |
| Cash, Cash Equivalents and Short-Term Investments | 1.53M | 8.81M | 7.82M | 9.97M | 3.87M | 1.49M |
| Total Debt | 3.19M | 2.45M | 1.16M | 1.39M | 2.26M | 752.00K |
| Total Liabilities | 19.50M | 26.62M | 20.65M | 19.02M | 15.94M | 12.94M |
| Stockholders Equity | 10.18M | 11.26M | 13.71M | 13.82M | 9.41M | 10.37M |
Cash Flow | ||||||
| Free Cash Flow | -3.06M | 3.25M | -522.00K | 8.11M | 3.71M | 2.58M |
| Operating Cash Flow | -2.77M | 3.84M | 1.65M | 9.19M | 4.59M | 2.80M |
| Investing Cash Flow | -116.00K | -223.00K | -1.93M | -1.04M | -822.00K | -190.00K |
| Financing Cash Flow | -2.26M | -2.63M | -1.88M | -2.05M | -1.39M | -567.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.33B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
67 Neutral | £288.03M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
65 Neutral | £1.62B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
63 Neutral | £480.59M | 11.70 | 7.52% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £34.87M | -3.95 | 15.03% | ― | 16.66% | 147.92% | |
53 Neutral | £49.85M | -28.65 | -10.09% | 2.09% | -5.97% | 14.75% |